(Q37835621)

24 August 2017

1 reference

title

C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians (English)

1 reference

24 August 2017

author name string

Elizabeth B Windgassen

1

1 reference

24 August 2017

Luciana Funtowicz

2

1 reference

24 August 2017

Tisha N Lunsford

3

1 reference

24 August 2017

Lucinda A Harris

4

1 reference

24 August 2017

Sharon L Mulvagh

5

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

24 August 2017

published in

Postgraduate Medicine

1 reference

24 August 2017

volume

123

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

114-119

1 reference

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

What does minor elevation of C-reactive protein signify?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein, inflammatory conditions, and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Race and gender differences in C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Blood pressure, C-reactive protein, and risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

The role of C-reactive protein as a prognostic indicator in advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Prognostic factors in advanced gastrointestinal cancer patients with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Evaluation of patients with a painful total knee replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

A simple, cost-effective screening protocol to rule out periprosthetic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.01.2252

21 January 2018

Identifiers

DOI

10.3810/PGM.2011.01.2252

1 reference

24 August 2017

1 reference